Bharat Rasayan Limited, at its board meeting held on February 12, 2026, announced its un-audited financial results for the quarter and nine months ended December 31, 2025. For the quarter ended December 31, 2025, the company reported a total income of ₹402.05 Crores, representing a significant increase of 40.60% compared to the previous quarter’s (QoQ) income of ₹285.96 Crores. When compared to the corresponding quarter of the previous year (YoY), the revenue grew by 57.03% from ₹256.04 Crores. The net profit for the current quarter stood at ₹40.04 Crores, showcasing a growth of 53.06% from the previous quarter’s profit of ₹26.16 Crores and a substantial 132.79% increase from ₹17.20 Crores in the same quarter last year. This robust performance highlights a strong recovery and operational efficiency during the period.

Bharat Rasayan Limited is a prominent Indian agrochemical company established in 1989, specializing in the manufacture of technical-grade pesticides, intermediates, and bulk chemicals essential for crop protection. The company operates a well-diversified business model with a strong R&D focus and a distribution network spanning over 24 countries, including the US, Switzerland, and Japan. In recent 2025 updates, the company successfully executed a 1:2 stock split and a 1:1 bonus issue on December 15, 2025, to enhance share liquidity and reward its shareholders. Furthermore, the company is evaluating a strategic ₹500 Crore capital expenditure for a new plant in Gujarat to capitalize on the growing demand in the chemical industry. Notable institutional investors include PGIM India Midcap Fund and PGIM India Small Cap Fund, which significantly increased their holdings as of December 31, 2025.